Antibody-displaying Exosomes

Product List

+ Filter
Loading...
View More Products

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

Introduction of Antibody-displaying Exosomes

Extracellular vesicles (EVs) are natural nanoparticles acting as a form of cell-to-cell communication. EVs act as key mediators in transferring biological signals between cells, carrying a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids. This inherent capability has generated substantial interest in leveraging EVs for therapeutic applications. EVs can be engineered to display antibodies on their surface, enabling targeted delivery of therapeutic cargos. This innovative approach combines the specificity of antibodies, which are designed to recognize and bind to antigens on target cells, with the delivery capabilities of EVs, which can efficiently transport these antibodies and their attached payloads across biological barriers and into recipient cells, offering a promising strategy for various applications. The ability of EVs to deliver macromolecular content, such as drugs, proteins, and genetic material, and to traverse physiological barriers, along with their inherent biocompatibility and minimal toxicity, makes them ideal for drug delivery and therapeutic applications, offering advantages over synthetic carriers.

Extracellular vesicles with antibodies effectively targeted to specific cells or tissuesFig. 1 Extracellular vesicles (EVs) with antigen-specific antibodies increase the specificity of cells or tissues.1, 3

FAQs About Antibody-displaying Exosomes

1. What are extracellular vesicles (EVs)?

  • EVs are small vesicles released by cells that play a role in intercellular communication. They can transport various molecules, including proteins, RNA, and lipids, between cells.
  • How can antibody-displaying exosomes improve drug delivery?
  • By displaying antibodies on their surface, EVs can be targeted to specific cells or tissues, enhancing the delivery of therapeutic cargos to desired locations.
  • What types of antibodies can be displayed on EVs?
  • EVs can be engineered to display a wide range of antibodies, including monoclonal antibodies, offering versatility in targeting various cell types and antigens.
  • What are the advantages of using antibody-displaying exosomes over other drug delivery systems?
  • Antibody-displaying exosomes offer high biocompatibility, low toxicity, and the ability to cross biological barriers, making them effective for targeted drug delivery.
  • Are antibody-displaying exosomes suitable for all therapeutic applications?
  • Antibody-displaying exosomes can be tailored for various therapeutic applications, including cancer therapy, immunotherapy, and regenerative medicine. Contact us to discuss the suitability of our antibody-displaying exosome solutions for your specific needs.

Our Antibody-displaying Exosome Products

Creative Biolabs offers a comprehensive suite of custom EV engineering services and products that can help you achieve your research. Our antibody-displaying exosome solutions provide a robust and versatile platform to enhance the delivery of your therapeutic payloads. Our technology enables the engineering of EVs to display antibodies on their surface, which can then be used to target specific cell types or tissues. This technology offers solutions for targeted drug delivery, immunotherapy, and basic research.

  • Antibody Design and Engineering: We design, and engineer antibody constructs suitable for EV surface display, ensuring optimal binding affinity and specificity.
  • EV Production: We generate EVs from producer cells engineered to express the antibody constructions.
  • Antibody Display Optimization: We optimize the EV production process to maximize antibody display on the EV surface.
  • Customization: We decorate EVs with client-provided antibodies.
  • Quality Control and Validation: We perform rigorous quality control and validation assays to ensure the EVs meet the required specifications (size, antibody display, purity, etc.).
  • Cargo Loading: Therapeutic cargo is loaded into the antibody-displaying EVs.
  • Functionalization: If required, additional approaches to functionalize the antibody display.

Engineered EVs decorated with different types of antibodiesFig. 2 Engineered EVs can be decorated with different types of antibodies (mAb).2, 3

Creative Biolabs have deep expertise in EV biology, antibody engineering, and drug delivery. Our tailored services, cutting-edge technology, and rigorous quality control ensure reliable and effective solutions. Please contact us for more information on these and other related offers.

References
  1. Nazimek, Katarzyna, and Krzysztof Bryniarski. "Increasing the therapeutic efficacy of extracellular vesicles from the antigen-specific antibody and light chain perspective." Frontiers in Cell and Developmental Biology 9 (2021): 790722.
  2. Wiklander, Oscar PB, et al. "Antibody-displaying extracellular vesicles for targeted cancer therapy." Nature biomedical engineering (2024): 1-16.
  3. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use.

Go to compare

Go to compare